Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing

Patients with MDR and RR TB require radical changes in treatment compared to those with drug-susceptible TB. Global roll-out of rapid molecular assays has revolutionized the diagnosis of DR-TB. Over the past decade, WGS of Mycobacterium tuberculosis has proved to be an extraordinary tool in the study and control of TB. A small bacterial genome of Mycobacterium tuberculosis makes it the perfect candidate for this kind of technology.